Telithromycin inhibits the number of viable bacteria but not lymphocyte accumulation in a murine model of chronic respiratory infection

Chemotherapy

Volumn 53, Issue 1, 2007, Pages 10-13

  Yanagihara, Katsunori ^a,b   Kuroki, Misuzu ^a   Higuchi, Norihide ^a   Ohno, Hideaki ^a   Higashiyama, Yasuhito ^a   Miyazaki, Yoshitsugu ^a   Hirakata, Yoichi ^a   Mukae, Hiroshi ^a   Tomono, Kazunori ^a   Mizuta, Yohei ^a   Kadota, Jun Ichi ^a   Tsukamoto, Kazuhiro ^a   Kohno, Shigeru ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic respiratory infection; Murine model; Pseudomonas aeruginosa; Telithromycin

Indexed keywords

CLARITHROMYCIN; TELITHROMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL VIABILITY; BIOFILM; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; EXPERIMENTAL MOUSE; IN VIVO STUDY; LUNG; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOFILMS; CHRONIC DISEASE; CLARITHROMYCIN; DISEASE MODELS, ANIMAL; KETOLIDES; LUNG; LYMPHOCYTES; MALE; MICE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EID: 33846424586     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000098244     Document Type: Article

References (14)

1. Fogarty CM, Kohno S, Buchanan P, Aubier M, Baz M: Community-acquired respiratory tract infections caused by resistant pneumococci: clinical and bacteriological efficacy of the ketolide telithromycin. J Antimicrob Chemother 2003;51:947-955.
2. Reinert RR, Rodloff AC, Halle E, Baer W, Beyreiss B, Seifert H, Wichelhaus TA, Maass M, Mehl M: Antibacterial resistance of community-acquired respiratory tract pathogens recovered from patients in Germany and activity of the ketolide telithromycin: results from the PROTEKT Surveillance Study (1999-2000). Chemotherapy 2004;50:143-151.
3. Reinert RR, Lütticken R, Reinert S, Al-Lahham A, Lemmen S: Antimicrobial resistance of Streptococcus pneumoniae isolates of outpatients in Germany, 1999-2000. Chemotherapy 2004;50:184-189
4. Bryskier A: Ketolides - telithromycin, an example of a new class of antibacterial agents. Clin Microbiol Infect 2000;6:661-669.
5. Kudoh, S, Azuma A, Yamamoto M, Izumi T, Ando M: Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157:1829-1832.
6. Vazifeh D, Bryskier A, Labro MT: Effect of proinflammatory cytokines on the interplay between roxithromycin, HMR 3647, or HMR 3004 and human polymorphonuclear neutrophils. Antimicrob Agents Chemother 2000;44:511-521.
7. Araujo FG, Slifer TL, Remington JS: Inhibition of secretion of interleukin-1α and tumor necrosis factor α by the ketolide antibiotic telithromycin. Antimicrob Agents Chemother 2002;46:3327-3330.
8. Yanagihara K, Tomono K, Sawai T, Hirakata Y, Kadota J, Koga H, Tashiro T, Kohno S: Effect of clarithromycin on lymphocytes in chronic respiratory Pseudomonas aeruginosa infection. Am J Respir Crit Care Med 1997;155:337-342.
9. Yanagihara K, Tomono K, Sawai T, Kuroki M, Kaneko Y, Ohno H, Higashiyama Y, Miyazaki Y, Hirakata Y, Maesaki S, Kadota J, Tashiro T, Kohno S: Combination therapy for chronic Pseudomonas aeruginosa respiratory infection associated with biofilm formation. J Antimicrob Chemother 2000;46:69-72.
10. Yanagihara K, Tomono K, Imamura K, Kaneko Y, Kuroki M, Sawai T, Miyazaki Y, Hirakata Y, Mukae H, Kadota J, Kohno S: Effect of clarithromycin on chronic respiratory infection caused by Pseudomonas aeruginosa with biofilm formation in an experimental murine model. J Antimicrob Chemother 2002;49:867-870.
11. Yanagihara K, Tomono K, Kuroki M, Kaneko Y, Sawai T, Ohno H, Higashiyama Y, Miyazaki Y, Maesaki S, Kadota J, Kohno S: Intrapulmonary concentrations of inflammatory cytokines in a mouse model of chronic respiratory infection caused by Pseudomonas aeruginosa. Clin Exp Immunol 2000;121:67-71.
12. Abraham E, Fretas AA, Coutino AA: Purification and characterization of intraparenchymal lung lymphocytes. J Immunol 1990;144:2117-2122.
13. Jacobs MR, Bajaksouzian S, Appelbaum PC: Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci. J Antimicrob Chemother 2003;52:809-812.
14. Gustafsson I, Engstrand L, Cars O: In vitro pharmacodynamic studies of activities of ketolides HMR 3647 (telithromycin) and HMR 3004 against extracellular or intracellular Helicobacter pylori. Antimicrob Agents Chemother 2001;45:353-355.